Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Singular Genomics Systems, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 62 | 48 | −14 |
| Shares | 32.8M | 27.0M | −5.84M (−17.8%) |
| Value | $27.3M | $10.6M | −$16.7M (−61.3%) |
New holders (1)
Institutions that held Singular Genomics Systems, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| QVIDTVM Management LLC | 1,188,377 | $452.8K | 0.35% |
Sold out (15)
Institutions that held Singular Genomics Systems, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Coatue Management LLCSuperinvestorCoatue Management | 1,679,372 | $1.39M |
| Y-Intercept (Hong Kong) Ltd | 154,007 | $127.8K |
| Susquehanna International Group, LLP | 108,026 | $89.7K |
| Old Mission Capital LLC | 95,067 | $78.9K |
| Gsa Capital Partners LLP | 75,102 | $62.0K |
| Ergoteles LLC | 55,800 | $46.3K |
| Charles Schwab Investment Management Inc | 23,488 | $19.5K |
| Point72 Middle East FZE | 19,568 | $16.2K |
| Deutsche Bank AG | 19,474 | $16.2K |
| Captrust Financial Advisors | 16,136 | $13.4K |
| Balyasny Asset Management LLC | 13,897 | $11.5K |
| Point72 Asset Management, L.P. | 7,437 | $6.17K |
| Cubist Systematic Strategies, LLC | 6,098 | $5.06K |
| Clearstead Advisors, LLC | 1,500 | $1.25K |
| New York State Common Retirement Fund | 509 | $422 |